These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8422738)
21. [Parkinson's disease: modern evolution]. Guillard A Soins; 1993 May; (572):8-11. PubMed ID: 8303420 [No Abstract] [Full Text] [Related]
22. Rational management of the 'on-off' syndrome in Parkinson's disease. Coleman RJ Q J Med; 1990 Feb; 74(274):121-31. PubMed ID: 2189148 [No Abstract] [Full Text] [Related]
23. Basal ganglia, Parkinson's disease and levodopa therapy. Proceedings of a meeting. St Thomas, Virgin Islands, January 2000. Trends Neurosci; 2000 Oct; 23(10 Suppl):S1-126. PubMed ID: 11221749 [No Abstract] [Full Text] [Related]
24. Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease. Fernandez HH; Odin P Curr Med Res Opin; 2011 May; 27(5):907-19. PubMed ID: 21351823 [TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacology review of opicapone for the treatment of Parkinson's disease. Fabbri M; Rosa MM; Ferreira JJ Neurodegener Dis Manag; 2016 Oct; 6(5):349-62. PubMed ID: 27599671 [TBL] [Abstract][Full Text] [Related]
26. The effect of dopaflex on the clinical picture and reaction time of parkinsonian patients. Antal J Ther Hung; 1974; 22(2):70-8. PubMed ID: 4419534 [No Abstract] [Full Text] [Related]
27. Balance and Gait Represent Independent Domains of Mobility in Parkinson Disease. Horak FB; Mancini M; Carlson-Kuhta P; Nutt JG; Salarian A Phys Ther; 2016 Sep; 96(9):1364-71. PubMed ID: 27034314 [TBL] [Abstract][Full Text] [Related]
29. Current status of clinical pharmacology training in the United States. Peck CC; Crout JR Clin Pharmacol Ther; 1986 Apr; 39(4):451-8. PubMed ID: 3956065 [No Abstract] [Full Text] [Related]
38. Effect of levodopa treatment on contrast sensitivity in Parkinson's disease. Bulens C; Meerwaldt JD; Van der Wildt GJ; Van Deursen JB Ann Neurol; 1987 Sep; 22(3):365-9. PubMed ID: 3674801 [TBL] [Abstract][Full Text] [Related]
39. Risk factors and safe dosage of levodopa for wearing-off phenomenon in Chinese patients with Parkinson's disease. Chen H; Fang J; Li F; Gao L; Feng T Neurol Sci; 2015 Jul; 36(7):1217-23. PubMed ID: 25616444 [TBL] [Abstract][Full Text] [Related]